Form D · Biotechnology
ALLEGRO DIAGNOSTICS CORP
Maynard, MA · CIK 0001428458
Offering snapshot reported Jul 13, 2011 · SEC filing
- Reported sold
- $5.4M Offering amount: $6.66M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 29, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2011 | Initial | $5,397,580 | No comparison | 5 | SEC filing |
| Feb 26, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-162821
Offering of Series A Preferred Stock
Source: Form D, filed Jul 13, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jerome Brody | Director |
| Stephen Chubb | Director |
| Joshua Phillips | Director |
| Avrum Spira | Director |
| Michael D. Webb | Director, Executive |
| Andrey Zarur | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6 Clock Tower Place Suite 225
Maynard, MA, 01754
Maynard, MA, 01754